KLRK1 and cancer: Furthermore, in other studies involving samples from patients with different malignancies, it was noted that a large proportion of CD4+NKG2D+ T cells with regulatory activity was largely dependent of FasL and NKG2D ligands [24], supporting the idea that an immunosuppressive property distinguishes these cells in some circumstances, such as cancer.